Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Start Further Info
FOR FURTHER INFORMATION CONTACT:
Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.
End Further Info
Start Supplemental Information
The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.
Table 1—List of Information Collections Approved by OMB
|Title of collection||OMB control No.||Date approval
|Formal Meetings Between the Food and Drug Administration and Sponsors and Applicants of Prescription Drug User Fee Act Products||0910-0429||5/31/2023|
|Special Protocol Assessments||0910-0470||5/31/2023|
|Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements||0910-0606||5/31/2023|
|Tracking Network for PETNet, LivestockNet, and SampleNet||0910-0680||5/31/2023|
|Center for Tobacco Products, Food and Drug Administration Funded Trainee/Scholar Survey||0910-0887||5/31/2023|
|Importer's Entry Notice||0910-0046||6/30/2023|
|Premarket Notification Submission 510(k), Subpart E||0910-0120||6/30/2023|
|Medical Devices; Pediatric Uses of Devices; Requirement for Submission of Information on Pediatric Subpopulations||0910-0748||6/30/2023|
|Controlled Correspondence Related to Generic Drug Development||0910-0797||6/30/2023|
|Certification of Identity for Freedom of Information Act and Privacy Act Requests||0910-0832||6/30/2023|
|FDA Advisory Committee Membership Nominations||0910-0833||6/30/2023|
End Supplemental Information
Dated: July 6, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-14875 Filed 7-9-20; 8:45 am]
BILLING CODE 4164-01-P